Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Trial details
- Registry ID
- NCT05099770
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseNCT05099770 | Prokidney | Phase 3 | Active not recruiting | 2029-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |